Clinical Trials

38 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT04863248 2023-04-14

PRESERVE 4

10 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT02128243 2021-03-26

MATEO

242 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT02831491 2020-06-09

A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00582582 2019-12-13

Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer

70 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT00979641 2019-03-28

AINO

65 enrolled

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT02007148 2019-02-27

MICADO

Phase 2 Unknown

51 enrolled

Neoplasm Metastasis, Recurrence

NCT00454779 2018-10-17

PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response

113 enrolled 18 charts

Neoplasm Metastasis, Recurrence

NCT00428922 2018-08-09

Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients

26 enrolled 5 charts

Breast Neoplasms, Neoplasm Metastasis

NCT02793765 2017-10-30

Docetaxel Followed by Provenge in Metastatic Prostate Cancer

Phase 2 Withdrawn

Neoplasm Metastasis, Prostatic Neoplasms

NCT02474186 2017-08-03

Phase II Study for Solid Metastatic Tumors

41 enrolled

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT02105675 2017-05-24

Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer

60 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT03147963 2017-05-10

Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer

Phase 2 Unknown

90 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT00498797 2016-10-07

E3-Hormone Refractory Prostrate Cancer Taxotere Combination

86 enrolled 8 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT00047840 2016-08-25

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

129 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00390416 2016-03-14

Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma

48 enrolled 8 charts

Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT00377559 2015-10-06

MYOTAX

70 enrolled

Breast Neoplasms, Neoplasm Metastasis, Cardiotoxicity

NCT00377780 2015-09-23

MYOHERTAX

60 enrolled

Breast Neoplasms, Neoplasm Metastasis, Cardiotoxicity

NCT00697060 2015-06-24

A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT01069081 2015-03-06

Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer

94 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01038804 2013-09-18

A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer

101 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT00554918 2013-08-07

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy

300 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT00084825 2012-10-26

Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008

23 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT00080678 2012-10-12

Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases

116 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT00356122 2011-10-17

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

53 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT00232206 2011-05-18

Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer

40 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT00571675 2010-11-09

A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)

220 enrolled

Disease, Neoplasm Metastasis, Prostatic Neoplasms

NCT00541281 2009-10-27

Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer

150 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT00980603 2009-09-21

Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer

Phase 2 Unknown

144 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT00142038 2007-04-18

Docetaxel and Capecitabine in Advanced Gastric Cancer

80 enrolled